99% Purity CAS 2156-56-1 Sodium Dichloroacetate Raw Material Sodium Dichloroacetate Powder Sodium Dichloroacetate

• Powder: Yes
• Customized: Customized
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Adult
• State: Powder
• Purity: >99%
• Model NO.: Dsung-Sodium Dichloroacetate
• Product Name: Sodium Dichloroacetate
• Name: Sodium Dichloroacetate Powder
• Appearance: White Powder
• Grade: Pharmaceutical Grade
• Assay: HPLC 99%
• Application: Anti-Cancer
• Specific: COA
• Test Method: HPLC
• Shelf Life: 2 Years
• CAS No.: 2156-56-1
• Mf: C2HCl2nao2
• MW: 150.92391
• Melting Point: 198 C (DEC.)
• Boiling Point: 194 Cat 760mmhg
• Density: Relative Density (Water = 1): 1.56
• Transport Package: Negotiable
• Specification: 99%
• Trademark: D-Sung
• Origin: Shaanxi
• Production Capacity: 500kg/Month

Product Description

99% Purity CAS 2156-56-1 Sodium Dichloroacetate Raw Material Sodium Dichloroacetate Powder Sodium Dichloroacetate

 

Product Description

Product Details

Product Name	Sodium Dichloroacetate
CAS No.	2156-56-1
MF	C2HCl2NaO2
MW	150.92391
Appearance and shape	White powder

Sodium dichloroacetate (DCA) is a mitochondrial pyruvate dehydrogenase kinase inhibitor, and is an orally absorbable small molecular compound for MELAS syndrome, and children with congenital lactic acidosis and other diseases that are treated in the clinic. Recent studies had found that DCA acts as a potential vasoprotective agent by inhibiting PDK2 and reducing coronary endarterium proliferation. Further, DCA promotes brain regeneration after cerebral ischemia, which indicates that DCA might play an important role in VD.

Application & Function

DCA acts as an inhibitor of cell growth in vivo and in vitro without causing programmed cell death (apoptosis).DCA is a safe drug with no toxicity to the heart, lungs, kidneys or bone marrow.The most serious side effects include peripheral neuropathy, which is reversible.DCA has anticancer activity in several cancer types, including colon, prostate, ovarian, neuroblastoma, lung, cervical, endometrial, cholangiocarcinoma, sarcoma, and T-cell lymphoma.

Specification